Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
2.14M
-
Shares change
-
+639K
-
Total reported value, excl. options
-
$20.7M
-
Value change
-
+$6.19M
-
Number of buys
-
6
-
Number of sells
-
-9
-
Price
-
$9.70
Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q4 2019
21 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q4 2019.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.14M shares
of 120M outstanding shares and own 1.78% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1.37M shares), Artal Group S.A. (630K shares), RENAISSANCE TECHNOLOGIES LLC (60.6K shares), BlackRock Inc. (34K shares), VANGUARD GROUP INC (11.5K shares), MILLENNIUM MANAGEMENT LLC (11.5K shares), Verition Fund Management LLC (11.3K shares), WELLS FARGO & COMPANY/MN (6.03K shares), Tower Research Capital LLC (TRC) (1.3K shares), and INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC (297 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.